Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular and tissue environment of a damaged tendon refers to the complex, altered microenvironment characterized by a shift from a highly organized collagenous matrix to a disorganized, hypercellular, and hypervascular state. In this environment, resident tenocytes undergo phenotypic changes, often increasing the production of collagen type III relative to type I, which results in reduced mechanical strength (Millar et al., 2021). The milieu is further defined by an influx of inflammatory mediators, such as IL-1β and TNF-α, and an increased activity of matrix metalloproteinases (MMPs) that degrade the extracellular matrix (Sharma & Maffulli, 2005). Neovascularization is also a hallmark of this environment, often accompanied by nerve ingrowth which contributes to the clinical presentation of pain (D'Addona et al., 2017). While not a single molecular target, this environment serves as a therapeutic landscape where pharmacological agents aim to restore homeostatic mechanotransduction and matrix integrity. Current interventions, including corticosteroids and growth factors, attempt to modulate this environment to favor repair over degeneration (Xu et al., 2020). Understanding the interplay between the various cell types and the biochemical signals within this niche is essential for developing effective regenerative therapies.
Modulation of inflammatory cytokines, stimulation of collagen synthesis, and enzymatic degradation of pathological collagen fibers.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular and tissue environment of damaged tendon.